Probiotics enhance resistance to Streptococcus iniae in Nile tilapia (Oreochromis niloticus) reared in biofloc systems

被引:4
|
作者
Padeniya, Uthpala [1 ]
Davis, D. Allen [1 ]
Liles, Mark R. [2 ]
LaFrentz, Stacey A. [2 ]
LaFrentz, Benjamin R. [3 ]
Shoemaker, Craig A. [3 ]
Beck, Benjamin H. [3 ]
Wells, Daniel E. [4 ]
Bruce, Timothy J. [1 ,5 ]
机构
[1] Auburn Univ, Sch Fisheries Aquaculture & Aquat Sci, Auburn, AL USA
[2] Auburn Univ, Dept Biol Sci, Auburn, AL USA
[3] USDA ARS, Aquat Anim Hlth Res Unit, Auburn, AL USA
[4] Auburn Univ, Dept Hort, Auburn, AL USA
[5] Auburn Univ, Sch Fisheries Aquaculture & Aquat Sci, Auburn, AL 36849 USA
基金
美国食品与农业研究所;
关键词
Bacillus spp; gene expression; lysozyme activity; pathogen challenge; CHANNEL CATFISH; IMMUNE-RESPONSE; CYTOKINE EXPRESSION; GENE-EXPRESSION; TECHNOLOGY BFT; WATER-QUALITY; AQUACULTURE; GROWTH; FISH; INTERLEUKIN-8;
D O I
10.1111/jfd.13833
中图分类号
S9 [水产、渔业];
学科分类号
0908 ;
摘要
Biofloc technology is a rearing technique that maintains desired water quality by manipulating carbon and nitrogen and their inherent mixture of organic matter and microbes. Beneficial microorganisms in biofloc systems produce bioactive metabolites that may deter the growth of pathogenic microbes. As little is known about the interaction of biofloc systems and the addition of probiotics, this study focused on this integration to manipulate the microbial community and its interactions within biofloc systems. The present study evaluated two probiotics (B. velezensis AP193 and BiOWiSH FeedBuilder Syn 3) for use in Nile tilapia (Oreochromis niloticus) culture in a biofloc system. Nine independent 3785 L circular tanks were stocked with 120 juveniles (71.4 +/- 4.4 g). Tilapia were fed for 16 weeks and randomly assigned three diets: a commercial control diet or a commercial diet top-coated with either AP193 or BiOWiSH FeedBuilder Syn3. At 14 weeks, the fish were challenged with a low dose of Streptococcus iniae (ARS-98- 60, 7.2 x 10(7) CFU mL(-1), via intraperitoneal injection) in a common garden experimental design. At 16 weeks, the fish were challenged with a high dose of S. iniae (6.6 x 10(8) CFU mL(-1)) in the same manner. At the end of each challenge trial, cumulative per cent mortality, lysozyme activity and expression of 4 genes (il-1 ss, il6, il8 and tnf alpha) from the spleen were measured. In both challenges, the mortalities of the probiotic-fed groups were significantly lower (p <.05) than in the control diet. Although there were some strong trends, probiotic applications did not result in significant immune gene expression changes related to diet during the pre-trial period and following exposure to S. iniae. Nonetheless, overall il6 expression was lower in fish challenged with a high dose of ARS-98- 60, while tnf alpha expression was lower in fish subjected to a lower pathogen dose. Study findings demonstrate the applicability of probiotics as a dietary supplement for tilapia reared in biofloc systems.
引用
收藏
页码:1137 / 1149
页数:13
相关论文
共 50 条
  • [1] Establishment of a Model of Streptococcus iniae Meningoencephalitis in Nile Tilapia (Oreochromis niloticus)
    Baums, C. G.
    Hermeyer, K.
    Leimbach, S.
    Adamek, M.
    Czerny, C. -P.
    Hoerstgen-Schwark, G.
    Valentin-Weigand, P.
    Baumgaertner, W.
    Steinhagen, D.
    JOURNAL OF COMPARATIVE PATHOLOGY, 2013, 149 (01) : 94 - 102
  • [2] STREPTOCOCCUS INIAE OUTBREAKS IN BRAZILIAN NILE TILAPIA (OREOCHROMIS NILOTICUS L.) FARMS
    Figueiredo, H. C. P.
    Nobrega Netto, L.
    Leal, C. A. G.
    Pereira, Ulisses P.
    Mian, Glaucia F.
    BRAZILIAN JOURNAL OF MICROBIOLOGY, 2012, 43 (02) : 576 - 580
  • [3] Characterization of Streptococcus iniae ghost vaccine and its immunization in Nile tilapia (Oreochromis niloticus)
    Wang, Qishuo
    Zhang, Chao
    Xu, La
    Chen, Jiakang
    Wang, Xuepeng
    AQUACULTURE RESEARCH, 2021, 52 (04) : 1359 - 1368
  • [4] Hematological changes in nile tilapia (Oreochromis niloticus) infected with Streptococcus iniae by nare inoculation
    McNulty, ST
    Klesius, PH
    Shoemaker, CA
    Evans, JJ
    JOURNAL OF THE WORLD AQUACULTURE SOCIETY, 2003, 34 (03) : 418 - 422
  • [5] Serological and Molecular Characterization of Streptococcus iniae in Cultured Nile tilapia (Oreochromis niloticus) in Thailand
    Jantrakajorn, Sasibha
    Lukkana, Mintra
    Wongtavatchai, Janenuj
    THAI JOURNAL OF VETERINARY MEDICINE, 2014, 44 (01): : 49 - 58
  • [6] Pharmacokineties of oxytetracycline in nile tilapia Oreochromis niloticus challenged with Streptococcus iniae and Vibrio vulnificus
    Chen, CY
    Bowser, PR
    JOURNAL OF THE WORLD AQUACULTURE SOCIETY, 2005, 36 (03) : 262 - 270
  • [7] Growth response and acquired resistance of Nile tilapia, Oreochromis niloticus (L.) that survived Streptococcus iniae infection
    Shoemaker, Craig A.
    Lim, Chhorn
    Yildirim-Aksoy, Mediha
    Welker, Thomas L.
    Klesius, Phillip H.
    AQUACULTURE RESEARCH, 2006, 37 (12) : 1238 - 1245
  • [8] Development and efficacy of Streptococcus iniae live-attenuated vaccines in Nile tilapia, Oreochromis niloticus
    Heckman, Taylor, I
    Shahin, Khalid
    Henderson, Eileen E.
    Griffin, Matt J.
    Soto, Esteban
    FISH & SHELLFISH IMMUNOLOGY, 2022, 121 : 152 - 162
  • [9] Pathomorphology of experimental Streptococcus iniae infection in tilapia (Oreochromis niloticus)
    Donmez, A. E.
    Cengizler, I
    INDIAN JOURNAL OF ANIMAL RESEARCH, 2020, 54 (02) : 234 - 238
  • [10] Efficacy of a killed Streptococcus iniae vaccine in tilapia (Oreochromis niloticus)
    Klesius, PH
    Shoemaker, CA
    Evans, JJ
    BULLETIN OF THE EUROPEAN ASSOCIATION OF FISH PATHOLOGISTS, 1999, 19 (01): : 39 - 41